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Wnts are expressed in the forming long bones, suggesting roles in skeletogenesis. To examine the action of Wnts in skeleton
formation, we developed a genetic system to conditionally express Wnt4 in chondrogenic tissues of the mouse. A mouse Wnt4
cDNA was introduced into the ubiquitously expressed Rosa26 (R26) locus by gene targeting in embryonic stem (ES) cells. The
expression of Wnt4 from the R26 locus was blocked by a neomycin selection cassette flanked by loxP sites (floxneo) that was
positioned between the Rosa26 promoter and the Wnt4 cDNA, creating the allele designated R26
floxneoWnt4. Wnt4 expression
was activated during chondrogenesis using Col2a1-Cre transgenic mice that express Cre recombinase in differentiating
chondrocytes. R26
floxneoWnt4; Col2a1-Cre double heterozygous mice exhibited a growth deficiency, beginning approximately 7
to 10 days after birth, that resulted in dwarfism. In addition, they also had craniofacial abnormalities, and delayed ossification
of the lumbar vertebrae and pelvic bones. Histological analysis revealed a disruption in the organization of the growth plates
and a delay in the onset of the primary and secondary ossification centers. Molecular studies showed that Wnt4 overexpression
caused decreased proliferation and altered maturation of chondrocytes. In addition, R26
floxneoWnt4; Col2a1-Cre mice had
decreased expression of vascular endothelial growth factor (VEGF). These studies demonstrate that Wnt4 overexpression leads
to dwarfism in mice. The data indicate that Wnt4 levels must be regulated in chondrocytes for normal growth plate
development and skeletogenesis. Decreased VEGF expression suggests that defects in vascularization may contribute to the
dwarf phenotype.
Citation: Lee H-H, Behringer RR (2007) Conditional Expression of Wnt4 during Chondrogenesis Leads to Dwarfism in Mice. PLoS ONE 2(5): e450.
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INTRODUCTION
Wnt signaling has been implicated in the regulation of early
patterning and initial outgrowth of the vertebrate limb bud [1–4].
More recently, several Wnts have been shown to be expressed in
the developing long bones, suggesting that they may have roles in
endochondral bone formation. In the developing chick skeleton,
Wnt4 and Wnt9a (previously known as Wnt14) are expressed in
joint-forming regions, Wnt5a and Wnt11 in the perichondrium,
and Wnt5b in prehypertrophic chondrocytes of the growth plate
[5–8]. Misexpression studies in chick embryos suggested that both
Wnt4 and Wnt5a can alter chondrogenesis and shorten limb
growth, apparently by different mechanisms. Wnt4 accelerates
chondrocyte differentiation, whereas Wnt5a inhibits this process
[5]. Wnt9a misexpression has been shown to induce the initiation
of joint formation [6]. However, Wnt9a knockout mice formed
joints but had ectopic cartilaginous nodules that was enhanced by
loss of Wnt4 [9]. Wnt4/Wnt9a double mutants also had some limb
bone fusions apparently because of an inability to maintain joint
cell identity [10]. Misexpression of Wnt5b as well as Wnt5a inhibits
chondrogenesis in mice, but they appear to act differently. Wnt5a
inhibits the transition from resting to proliferating chondrocytes in
the growth plate, whereas Wnt5b promotes this transition as well as
chondrocyte proliferation [11].
Wnt signaling components have also been investigated for their
roles in skeletogenesis. Frb1, a secreted form of Frizzled that is
a Wnt receptor, can function as an antagonist when misexpressed
in long bone, causing shortening of skeletal elements, joint fusion,
and delayed chondrocyte maturation [12]. In addition, constitu-
tive expression of Lef1 in chondrocytes stimulated chondrocyte
maturation as well as replacement of cartilage by bone [13].
Furthermore, mice with a disruption of the LDL receptor-related
protein 5 (Lrp5) gene that encodes a Wnt co-receptor, showed
decreased osteoblast proliferation [14]. In addition, Lrp5-deficient
mice also displayed persistent eye vascularization. These bone and
eye phenotypes are similar to the abnormalities associated with
osteoporosis-pseudoglioma syndrome in human, caused by
mutation of LRP5 [15].
Most studies of Wnt signaling in skeleton development have
been restricted to the chick model. However, the expression of
Wnts appears to vary in different animal models. For example, in
addition to the perichondrium of chick, Wnt5a expression was also
found at the junction of proliferating and prehypertrophic
chondrocytes in the radius and ulna of mice [11].
Wnt4 expression has also been analyzed during kidney and
female reproductive system development. Wnt4 homozygous
mutant mice died after birth due to a failure of pretubular cell
aggregation, an essential step in the formation of nephrons of the
kidney [16]. In addition, Wnt4 mutant mice with an XX karyotype
lacked female-specific genital ducts and developed male-specific
genital ducts [17]. During chick skeletogenesis, Wnt4 is initially
expressed in joint-forming regions, and then is detected in the
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[5,18]. However at later stages, Wnt4 expression in long bones is
also detected in hypertrophic chondrocytes [18]. In the mouse,
Wnt4 is also expressed in forming joints and mesenchyme that will
form the joint capsule [19]. The patterns of Wnt4 expression in
chick and mouse suggest roles in joint development and
chondrocyte hypertrophy. In addition, the restricted pattern of
Wnt4 expression in bone-forming tissues suggests that its
expression must be precisely controlled to coordinate normal
bone and skeleton formation.
To study the actions of Wnt4 during skeleton development, we
created a conditional genetic system to express Wnt4 during
chondrogenesis. To accomplish this, we exploited the ubiquitously
expressed Rosa26 locus. The ROSA26 mouse mutant was originally
produced by infection of embryonic stem (ES) cells with a ROSAb-
geo retrovirus [20]. Rosa26 heterozygotes express b-galactosidase
(b-gal) reporter activity ubiquitously that initiates during pre-
implantation development at the morula-blastocyst stage. Exam-
ination of serial sections through 9.5 days post-coitus (dpc) Rosa26
heterozygotes demonstrated b-gal activity in all cells [21]. Rosa26
homozygous mutants are viable although they are recovered at
a lower than expected frequency [21]. The Rosa26 locus has been
used to ubiquitously or conditionally express various gene products
in mice [22–26]. Therefore, we exploited the Rosa26 locus to
express Wnt4 in a Cre-dependent manner. We placed a drug
selection cassette flanked by loxP sites between the Rosa26
promoter and a mouse Wnt4 cDNA, blocking Wnt4 expression
at the endogenous Rosa26 locus. Cre expression should delete the
blocking drug selection cassette, leading to Wnt4 expression.
To examine the action of Wnt4 during endochondral bone
formation, we used Col2a1-Cre transgenic mice that express Cre
activity in cartilage-forming tissues [27,28]. We found that Wnt4
expression in chondrogenic tissues alters skeletogenesis, resulting in
skull abnormalities and dwarfism. These studies indicate that
alterations in Wnt4 expression can cause severe skeletal pathologies.
RESULTS
Dwarfism in R26
floxneoWnt4; Col2a1-Cre mutant mice
A conditional genetic system was created to express Wnt4 in a Cre-
dependent manner, potentially in any tissue. We modified the
ubiquitously-expressed Rosa26 locus by gene targeting in ES cells
(Fig. 1A, B). A mouse Wnt4 cDNA was placed 39 of a floxed
neomycin resistance expression cassette, floxneo, which should
block the transcription of the Wnt4 cDNA from the Rosa26
promoter. This block in transcription should be relieved by Cre
recombinase-mediated excision of the floxneo cassette. ES cell
clones carrying the R26
floxneoWnt4 targeted allele were identified and
chimeras were generated that transmitted the targeted allele to
progeny. R26
floxneoWnt4 heterozygous and homozygous mutant mice
appeared normal and were fertile.
To activate the Wnt4 transgene, R26
floxneoWnt4 heterozygotes
were bred with Col2a1-Cre transgenic mice to generate R26
flox-
neoWnt4; Col2a1-Cre double heterozygotes, hereafter designated
mutants (Fig. 1C), that were obtained at the predicted Mendelian
ratio (,25%). The Col2a1-Cre transgene has been shown to initiate
Cre reporter activity as early as 8.5 dpc [27]. All R26
floxneoWnt4;
Col2a1-Cre mutants were viable and developed a dwarf phenotype
Figure 1. Generation of R26
floxneoWnt4 mice. A, Gene targeting strategy. Open box, R26 exon 1; DT-A, diphtheria toxin expression cassette. SA, splice
acceptor; X, XbaI. B, Southern analysis of ES cell clones. Genomic DNAs were digested with XbaI and detected by 59 external or 39 internal probes. C,
PCR genotyping of R26
floxneoWnt4; Col2a1-Cre mice. Primers shown in panel A (arrowheads) amplify R26 wild-type (,600-bp) and targeted (,350-bp)
alleles. Cre-specific primers yield a ,550-bp band to identify mice carrying the Col2a1-Cre transgene.
doi:10.1371/journal.pone.0000450.g001
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around 7 to 10 days after birth (data not shown). The body weights
of mutants and controls were measured starting from postnatal day
12 (P12) to P72 at 3-day intervals (Fig. 2B). Male and female
R26
floxneoWnt4; Col2a1-Cre mutants had similar body weight growth
rate characteristics. After weaning at 3 weeks of age, male mutants
were approxi-
mately 50 to 60% and female mutants were approximately 60 to
70%, of the body weight of their age- and sex-matched controls
(Fig. 2B).
Skeleton preparations of 6-week-old mice were examined
(Fig. 3A). In addition to shortened axial skeletons and limbs,
R26
floxneoWnt4; Col2a1-Cre mutants had smaller skulls (Fig. 3B). The
skulls had a dome-shaped neurocranium vault, shorter viscer-
ocranium, and a wider distance between the two orbits (Fig. 3B).
Separation of the dorsal skull bones revealed the parietal bones to
be fairly equal in size, the frontal and occipital bones to be slightly
smaller, and the nasal bones to be significantly shortened in
comparison to controls (Fig. 3C). The limbs of the R26
floxneoWnt4;
Col2a1-Cre mutants were disproportionately shorter than controls
(Fig. 3D, E).
R26
floxneoWnt4; Col2a1-Cre mutants also had lumbar vertebrae and
pelvic bone defects. The vertebrae of 6-week-old mutants were
narrow and flat as illustrated by the third lumbar vertebrae, which
showed a reduction in lateral bone (Fig. 3F). The posterior region
of the pelvic bone is composed of the pubic and ischial bones that
are fused in 6-week-old controls (Fig. 3G, H). However, these
bones retained cartilage between them in the mutants (Fig. 3G, I).
Ossification of the cartilage between these two bones was present
in 8-week-old mutants, although the pelvic bone was still thinner
than controls.
Radiographic analyses of 9-month-old mice showed that the
R26
floxneoWnt4; Col2a1-Cre mutants had small skeletons, dome-
shaped skulls, protruding incisors, and kyphosis of the cervical-
thoracic spine (Fig. 4). In addition, the 9-month-old mutants
moved slowly, suggesting that these skeletal abnormalities
Figure 2. Growth defects in R26
floxneoWnt4; Col2a1-Cre mutants. A, 4-
week-old R26
floxneoWnt4; Col2a1-Cre mutant and control littermates. The
mutant has a significantly shorter body and altered head shape relative
to the control. B, Mean body weight comparisons6standard error
between sex-matched mice from 12 to 72 days after birth. n=5 for
mutants, and n=6 for controls.
doi:10.1371/journal.pone.0000450.g002
Figure 3. Skeletal defects in R26
floxneoWnt4; Col2a1-Cre mutants.
Skeleton preparations from 6-week-old R26
floxneoWnt4; Col2a1-Cre
mutants and R26
floxneoWnt4controls. A, Intact skeletons, control (left)
and mutant (right). B, Dorsal view of skulls, control (left) and mutant
(right). C, individual dorsal skull bones, control (left) and mutant (right).
D, Isolated forelimbs, mutant (top) and control (bottom). E, Isolated
hindlimbs, mutant (top) and control (bottom). F, Third lumbar
vertebrae, showing lateral ossifications (arrow) in the control (left) that
are hypoplastic in the mutant (right). G, Isolated pelvic bones from 6-
week-old mice, control (left) and mutant (right). H, Higher magnification
of boxed region shown in panel G, showing pubic and ischial bone
fusion of the control. I, Higher magnification of boxed region shown in
panel G, showing lack of fusion between the pubic and ischial bones of
the mutant. fr, frontal bone; nas, nasal bone; par, parietal bone; oc,
occipital bone.
doi:10.1371/journal.pone.0000450.g003
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were observed in X-ray images of mutants and controls (Fig. 4).
Growth plate abnormalities in R26
floxneoWnt4; Col2a1-
Cre mutant mice
Tibiae and femurs of 15.5 dpc mutant mice were examined by
histology. At this stage of embryogenesis, the primary ossification
centers (POC) have developed in both the tibiae and femurs of
controls (Fig. 5A, C), with blood vessels originating from the
perichondrium present in the metaphysis. However, at this stage of
development in the mutants, the POC was not observed in tibiae
and had just started to form in femurs (Fig. 5B, D). At stages later
than 15.5 dpc, only sections of tibiae were used for comparisons.
At P1 and P5, there were no apparent differences between mutants
and controls (data not shown). Hypertrophic chondrocytes, ready
to be invaded by blood vessels in the future secondary ossification
center (SOC), were observed in controls at P7, but not in the
mutants. At P10, the secondary ossification centers of the controls
had started to form, and proliferating chondrocytes were
organized in columns (data not shown). In the same area of the
mutants, only hypertrophic chondrocytes were present. At P14,
most mutants had initiated hypertrophic chondrocyte develop-
ment in the SOC (Fig. 5E, F). The mutant growth plates were
also less organized, with less columnar organization, and some
hypertrophic chondrocytes had developed earlier than controls in
the zone of proliferating chondrocytes (Fig. 5E, F). The timing of
these histological alterations in bone formation correlate with the
initial growth defects observed in the mutants.
At P14, there were distinct differences in the chondrocyte zones
between R26
floxneoWnt4; Col2a1-Cre mutants and controls. The
proliferating chondrocyte zone in the tibiae of controls were
larger than mutants, yet the hypertrophic chondrocyte zone in
tibiae of mutants were larger than controls. At 3 weeks of age, both
mutants and controls have developed SOCs in tibiae, though they
were better developed in controls than in the mutants (data not
shown). At 9 months of age, the tibiae of mutants (n=2) were
deficient in bone marrow and were filled with adipocytes in
epiphyseal and metaphyseal regions (Fig. 5G, H). In contrast,
inspection of 12-month-old control mice (n=2) showed metaphy-
seal regions full of bone marrow (data not shown).
We employed section in situ hybridization using several molecular
markers, to study the chondrocyte zones in 3-week-old tibiae. Col2a1
is expressed in proliferating and prehypertrophic chondrocytes.
Col2a1 transcripts were detected in a smaller region in the mutants
Figure 4. Radiographic analysis for 9-month-old R26
floxneoWnt4; Col2a1-
Cre mutants. The mutants had a smaller skeleton, abnormal skulls with
a domed vault (arrowhead) and protruding incisors (small arrow).
Kyphosis (large arrow) of the cervical-thoracic spine was also





Figure 5. Histological analyses of long bones. A, C, E, G are H & E
stained histological sections of R26
floxneoWnt4 heterozygous controls; and
B, D, F, H are R26
floxneoWnt4; Col2a1-Cre mutants. A, B, 15.5 dpc tibiae. C,
D, 15.5 dpc femurs. The formation of the primary ossification center
(arrows) was delayed in both tibiae and femurs of the mutant in
comparison to controls. E, F, 2-week-old tibiae, showing development
of the secondary ossification center (black arrow) in the control but only
chondrocyte hypertrophy (black arrow) in the mutant that also had
a disorganized growth plate (red arrow). G, H, 9-month-old mutant tibia
with little bone marrow (G) filled with adipocytes (H, arrow).
doi:10.1371/journal.pone.0000450.g005
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a narrower zone of proliferating and prehypertrophic chondrocytes
(Fig. 6A, B). Indian hedgehog (Ihh), a member of the Hedgehog gene
family, is a key molecule in endochondral ossification [29]. At
postnatal stages, Ihh is expressed predominantly in prehypertrophic
chondrocytes. Hybridization of Ihh showed no obvious differences in
mutant tibiae relative to controls (Fig. 6C, D), suggesting that the
narrower zone defined by Col2a1 expression is predominantly due to
a reduced proliferating chondrocyte zone. Col10a1 is a marker of
prehypertrophic and hypertrophic chondrocytes, cells that have
exited the cell cycle [29]. Hypertrophic chondrocytes form the
terminal zone of the growth plate that is poised to become apoptotic
and replaced by bone. Col10a1 hybridized to a significantly larger
zone in the mutant growth plates in comparison to controls,
indicating a larger proportion of hypertrophic chondrocytes relative
to controls (Fig. 6E, F).
Gene expression of Wnt4 during skeletal development has been
described previously. In chick, Wnt4 expression is first detected at
embryonic stages in the joint regions between two long bones [5].
Another study showed Wnt4 expression in hypertrophic chon-
drocytes at later stages [18]. Using high-stringency for in situ
hybridization, Wnt4 transcripts were not detected in the growth
plates of 3-week-old control mice, but were found in almost the
entire cell population of the growth plates of the mutants (Fig. 6G,
H). Although we have not determined the earliest stage that the
Wnt4 transgene is activated by the Col2a1-Cre transgene these
results suggest that Cre acts in chondrogenic precursors to activate
Wnt4 transgene expression in all cells of the growth plate.
Chondrocyte proliferation was examined in 2-week-old mutants
and controls by BrdU-labeling (Fig. 7A, B). BrdU-labeling
revealed that the fraction of chondrocytes in the zone of
proliferation that incorporated BrdU was 0.18960.051 in controls
but only 0.12260.002 in mutants, resulting in a mitotic index of
0.64 for the R26
floxneoWnt4; Col2a1-Cre mutants (Fig. 7C). This
indicates that overexpression of Wnt4 leads to decreased
chondrocyte proliferation during tibial growth.
Decreased VEGF expression in R26
floxneoWnt4;
Col2a1-Cre mutant mice
During endochondral bone formation, VEGF induces angiogenesis
from the perichondrium. In mouse, VEGF has been reported to be
secreted by hypertrophic chondrocytes [30]. However, VEGF
immunostaining in 3-week-old wild-type tibiae was not restricted
to the terminal hypertrophic chondrocytes, but rather was pre-
dominantly expressed in prehypertrophic and early hypertrophic
chondrocytes (Fig. 8A). In R26
floxneoWnt4; Col2a1-Cre mutants, VEGF
immunostaining was weak in prehypertrophic chondrocytes and
almost absent in hypertrophic chondrocytes (Fig. 8B).
Figure 6. Section RNA in situ hybridization of tibial growth plates of
3-week-old animals. Molecular marker analysis of tibiae of 3-week-old
R26
floxneoWnt4 heterozygous control (A, C, E, G) and R26
floxneoWnt4; Col2a1-
Cre m u t a n t( B ,D ,F ,H )m i c e .Col2a1 marks proliferating and
prehypertrophic chondrocytes; Col10a1 marks prehypertropic chondro-
cytes; Ihh marks prehypertropic and hypertropic chondrocytes. Brackets
mark relevant regions. Wnt4 hybridization is undetectable in the growth
plate of the control, whereas Wnt4 transcripts are detected throughout
the growth plate of the mutant.
doi:10.1371/journal.pone.0000450.g006
Figure 7. Cell proliferation in the epiphyseal growth plate of the
proximal tibia. A, B, BrdU-labeled cells in 2-week-old control and
R26
floxneoWnt4; Col2a1-Cre mutant mice. C, The fraction of chondrocytes
in the proliferation zone (pz) that incorporated BrdU was 0.18960.051
in control mice compared to 0.12260.020 in mutants (P,0.001). The
labeling percentage of the control was designated as 1.0, and the
relative percentage of the mutant was calculated as 0.64.
doi:10.1371/journal.pone.0000450.g007
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An in vivo system to tissue-specifically overexpress
Wnt4 in mice
Wnt4 was initially shown to be essential for kidney tubulogenesis
for nephron formation [16] and differentiation of the female
gonad and reproductive tract [17]. Subsequently in chick, Wnt4
expression in the joint regions and misexpression studies indicated
a role in skeleton development [5]. To further study Wnt4 function
during development, we used a Cre/loxP system to conditionally
express Wnt4 from the ubiquitously-expressed Rosa26 locus
potentially in any mouse tissue in a Cre-dependent manner. To
study the activity of Wnt4 in skeletal development, we used Col2a1-
Cre transgenic mice that express Cre in chondrogenic tissues [27].
Examination of Wnt4 expression in the R26
floxneoWnt4; Col2a1-Cre
mutants suggested that Cre activates Wnt4 transcription in
chondrogenic precursors, leading to Wnt4 transgene expression
throughout the entire growth plate. These findings suggest that the
R26
floxneoWnt4 mice may also be useful for Wnt4 misexpression
studies in other tissues.
Overexpression of Wnt4 alters the growth plate
The external morphologies of the R26
floxneoWnt4; Col2a1-Cre mutants
were similar to mice with mutations in Fgfr3, Mt1-Mmp, and Link
protein (Hapln1) [31–36]. The length of the growth plates of the
R26
floxneoWnt4; Col2a1-Cre mutants was nearly identical to wild type,
although with an altered appearance. R26
floxneoWnt4; Col2a1-Cre
mutants have an expanded zone of hypertrophic chondrocytes and
a smaller zone of proliferating chondrocytes. Overexpression of
Wnt4 also causes a decrease in VEGF expression that may result in
a reduction of vascularization that in turn leads to delayed
formation of primary and secondary ossification centers. The
Col2a1-Cre transgene is active in chondrocyte precursors of
endochondral bones [27]. Interestingly, the skulls of the R26
flox-
neoWnt4; Col2a1-Cre mutants were significantly smaller than controls.
The skull is composed of elements derived from both endochon-
dral and membranous bone formation. The alterations observed
in the membranous bones of the mutant skulls may be indirect
effects of altered endochondral skull bones. All of the skeletal
alterations mentioned above likely contribute to the development
of the dwarf phenotype.
Wnt4 is expressed in the developing joint regions and a subset of
hypertrophic chondrocytes [5,18,19]. Wnt4 homozygous mutant
mice die within 24 hours after birth due to severe defects in kidney
function [16], but no skeletal abnormalities have been reported
[9]. However, Wnt4/Wnt9a double mutants show some joint cell
identity abnormalities [9,10]. The perinatal lethality precludes
studies of the role of Wnt4 in the skeleton after birth. Such studies
will require the generation of a Wnt4 conditional null allele [37].
Retroviral-mediated Wnt4 misexpression in chick limbs accelerat-
ed chondrocyte maturation; in contrast, Wnt5a misexpression in
the same model inhibited chondrocyte maturation [5]. Viral-
mediated misexpression of b-catenin or a constitutive-active form
of LEF/TCF display phenotypes similar to Wnt4 misexpression,
suggesting that Wnt4 influence on limb shortening may be mediated
by b-catenin [13]. In addition, viral-mediated misexpression of the
Wnt-antagonist Frzb-1 in growth plates delayed chondrocyte
differentiation [12]. Together these data imply that endogenous
Wnt4 signaling may have a role in chondrocyte maturation.
We show that overexpression of Wnt4 in the mouse growth plate
may also influence chondrocyte maturation, as shown by reduced
zones of proliferating chondrocytes and expanded zones of
Col10a1 hybridization and hypertrophic chondrocytes in R26
flox-
neoWnt4; Col2a1-Cre mutants. In addition, in growth plates of
R26
floxneoWnt4; Col2a1-Cre mutants, the zone of Col2a1 hybridization
was significantly smaller yet the Ihh zone essentially unchanged,
indicating a decrease in proliferating chondrocytes. The decrease
of the zone of proliferating chondrocytes may result from lower
rate of proliferation in mutants or a higher percentage of cells
exiting the proliferation state. However, an in vitro micromass
culture assay has shown that infection by a retroviral-delivered
Wnt4 did not decrease the rate of cell proliferation [18]. In
addition, no detectable change of cell proliferation was observed
by Wnt5a and 5b misexpresssion using the same system. Indeed,
recent studies in transgenic mice demonstrated that Wnt5b could
promote proliferation of chondrocytes in vivo [11]. These distinct
results may reflect the difference between mouse and chick models,
or differences between the in vitro and in vivo approaches. The
ability of Wnt4 to decrease the zone of proliferating chondrocytes
may represent an enhancement of the endogenous activity of
Wnt4, a competition with the activity of Wnt5b that promotes
proliferation of chondrocytes, or a mimicking of Wnt5a function
that inhibits the transition from resting chondrocytes to pro-
liferating chondrocytes. Moreover, since Wnt4 may accelerate the
differentiation of chondrocytes, proliferating chondrocytes with
overexpression of Wnt4 may exit the cell cycle rapidly, leading to
narrower zone of proliferating chondrocytes.
The R26
floxneoWnt4; Col2a1-Cre mutants also had disorganized
growth plates. The organized structure of the growth plate is
tightly linked between the chondrocytes and the extracellular
matrix (ECM) and Wnt actions on cell adhesion have been
proposed [38]. Overexpression of Wnt4 may interrupt such
a relationship, by either changing the cell membrane structure
of chondrocytes or altering components of the ECM. Wnt4 has
been shown to signal canonically, non-canonically, or through
neither pathway, depending upon the experimental context [39–
44]. It is not clear which pathway(s) is utilized for the Wnt4-
induced dwarfism documented in our study.
Overexpression of Wnt4 and skeleton
vascularization
The growth plates of R26
floxneoWnt4; Col2a1-Cre mutants displayed
decreased VEGF expression. VEGF is a key regulator for
vascularization and plays an important role during endochondral
bone formation, where VEGF couples hypertrophic cartilage
remodeling, ossification, and angiogenesis [30]. Vegf heterozygous
mice die at early embryonic stages [45,46], but animals that
express only the VEGF
120 isoform can survive to term. Vegf
120/120
mutants appeared to have low angiogenesis activity [47,48], and
share similar phenotypes with R26
floxneoWnt4; Col2a1-Cre mutants.
Figure 8. VEGF immunohistochemistry of 3-week-old tibiae. A, B,
VEGF immunostaining (brown) in growth plates of 3-week-old tibiae. A,
The control stained strongly for VEGF in prehypertrophic and
hypertrophic chondrocytes (arrow). B, VEGF immunostaining in the
R26
floxneoWnt4; Col2a1-Cre mutant tibia was weaker and restricted to
prehypertrophic chondrocytes (arrow).
doi:10.1371/journal.pone.0000450.g008
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primary and secondary ossification centers, reduction in mineral-
ization of mutant bone, and expansion of the zone of hypertrophic
chondrocytes. Thus, these phenotypes observed in the R26
flox-
neoWnt4; Col2a1-Cre mutants may be caused by overexpression of
Wnt4, causing reduced expression of VEGF.
Although the relationship between Wnt proteins and VEGF
during skeletal development has not yet been clarified, Wnt/b-
catenin signaling has been suggested to play a role in activation of
VEGF gene expression in benign colonic adenomas in which
mutant activated Wnt/b-catenin pathway is often associated with
up-regulated VEGF [49]. Moreover, after transfection of a dom-
inant-negative form of TCF4, one of the downstream molecular
components of Wnt signaling, VEGF expression was repressed.
Truncated VE-cadherin in mice, lacking the b-catenin-binding
cytosolic domain, impaired VEGF-mediated angiogenesis [50].
These results indicated that Wnt signaling mediated by the b-
catenin pathway could activate VEGF function, but this in
contradiction with the R26
floxneoWnt4; Col2a1-Cre mutant phenotype.
However, Wnt gene family members often exert distinct functions
in a particular tissue of the same stage. For instance, infection of
chick limbs using a retrovirus carrying Wnt5a or Wnt4 presented
distinct effects, with Wnt5a delaying chondrocyte differentiation,
whereas Wnt4 accelerated it [5]. Also, Wnt5b promoted the
transition of resting chondrocytes to proliferating chondrocytes,
whereas Wnt5a inhibited it [11]. This may reflect unique activities
of Wnt genes, or endogenously, Wnt proteins may function as
antagonists of each other.
Wnt4 is an important regulator of female reproductive organ
development in mice. The ovaries of female mice lacking Wnt4
were masculinized with indications of Leydig cell differentiation
[17]. In addition, the mutant ovaries had a large coelomic blood
vessel, a primary characteristic of the testis [51]. This has led to the
proposal that Wnt4 may repress angiogenesis in developing female
gonads, blocking the testis differentiation pathway.
The dwarfism of R26
floxneoWnt4; Col2a1-Cre mutants became
apparent only after birth. However, skeletal changes were found
earlier in development, consistent with the activity of the Col2a1-
Cre transgene at the initial stages of cartilage formation [27]. The
apparently weak response to transgenic Wnt4 at fetal stages may be
attributable to limited expression of Wnt4 receptors or an excess of
Wnt inhibitors. However, the overt dwarfism of the R26
floxneoWnt4;
Col2a1-Cre mutants may be the result of VEGF insufficiency.
Neonatal mice homozygous for a Vegf 120 isoform allele had 10%
shorter tibiae, and slight differences in bone length were detected
at 16.5 dpc in comparison to controls [47]. R26
floxneoWnt4; Col2a1-
Cre mutants may have stronger VEGF activity than VEGF
120/120
mutants because the phenotypes displayed in VEGF
120/120 mutants
were more severe than those of RWnt4; Col2a1-Cre mutants. For
example, the expansion of the zone of hypertrophic chondrocytes
was larger, and the delayed time of formation for the primary
ossification center was longer in Vegf
120/120 mutants. Thus, it may
be reasonable to expect that the shortening of tibial length
observed in R26
floxneoWnt4; Col2a1-Cre mutants as in Vegf
120/120
mutants becomes apparent only after birth.
In summary, Wnt4 is expressed during skeleton development.
The studies presented here demonstrate that dysregulated Wnt4
expression in chondrogenic tissues leads to skeletal defects and
dwarfism in mice. The data indicate that Wnt4 levels must be
regulated in chondrocytes for normal growth plate development
and skeletogenesis. In addition, these studies suggest that





The mouse Wnt4 cDNA encoding the entire open reading frame
was isolated by RT-PCR. RNA from 13.5 dpc gonads from mouse
strain 129/EvSvTac was isolated and used to synthesize cDNA.
The Wnt4 cDNA was subsequently amplified by two rounds of
PCR. The first primer set was: forward 59-CCGCGCGGCGA-
AAACCTG-39 and reverse 59-CTGTTTAAGTTATTGGCCT-
TC-39. The second primer set was: forward 59-GCCTTGGGAT-
CCCTGCCCCGGGCTGG-39 and reverse 59-ACGCAGGCG-
GCCGCACTAGTCCTAGGCATGGTCA-39. The final PCR
product was subcloned into the BamHI and NotI sites of
pBluescript KS(-) and sequenced.
The pR26-1 plasmid [22] was used to insert a conditional Wnt4
expression cassette into the Rosa26 locus. The expression cassette
begins with a splice acceptor sequence (SA), followed by Pgkneo and
five polyadenylation sequences flanked by loxP sites (floxneo). The
mouse Wnt4 cDNA followed by a bovine growth hormone poly-
adenylation (bpA) sequence was placed 39 of floxneo. The
expression cassette, SA-loxP-Pgkneo-5pA-loxP-Wnt4-bpA, was in-
serted into the XbaI site of pR26-1, to generate the gene targeting
vector (Fig. 1A). A diphtheria toxin expression cassette (DT)i s
present within pR26-1 for negative selection. The targeting vector
was linearized with KpnI and electroporated into AB1 ES cells and
selected in G418 [52]. ES cell clone genomic DNAs were digested
with XbaI and analyzed by Southern blot [53] using a 59 external
probe as described [22] and a 39 internal probe using bpA
(Fig. 1B). Targeted ES cell clones were injected into C57BL/6
(B6) blastocysts to generate chimeras that transmitted the
R26
floxneoWnt4 allele to their progeny. The R26
floxneoWnt4 allele was
examined on a B6129 mixed genetic background. The Col2a1-Cre
transgenic mice were originally generated on a B6SJLF2 genetic
background but have been backcrossed to B6 for .5 generations.
All procedures using animals were approved by the Institutional
Animal Care and Use Committee.
Mouse genotyping
The R26
floxneoWnt4 allele and Col2a1-Cre transgene were genotyped
by PCR using tail DNA (Fig. 1C). Two primer sets were used in
a single PCR reaction to identify the R26
floxneoWnt4 allele and the
Col2a1-Cre transgene. Primers for identifying the R26
floxneoWnt4
allele were, R26-R1:5 9-AAAGTCGCTCTGAGTTGTTAT-39,
R26-R2:5 9-GCGAAGCGTTTGTCCTCAACC-39, and R26-R3:
59-GGAGCGGGAGAAATGGATATG-39. Primers for identify-
ing the Col2a1-Cre transgene were, 59- TCCAATTTACTGACC-
GTACACCAA-39, and 59- CCTGATCCTGGCAATTTCGG-
CTA-39. PCR amplification was 40 cycles of 94uC for 30 sec,
62uC for 5 sec and 68uC for 60 sec. Approximately 600-bp and
350-bp fragments were amplified for the wild-type Rosa26 and
targeted alleles, respectively. The Col2a1-Cre transgene was
identified as a ,550-bp fragment.
Skeleton preparations and histology
6-week-old mice were prepared to visualize bone by alizarin red
staining as described [54]. For histological analysis, tissues were
fixed in 4% paraformaldehyde at 4uC overnight for pups at
postnatal day 7 (P7) or younger or for two days for pups older than
P7. After fixation, samples were washed twice in PBS and
decalcified with 0.5 M EDTA, pH 8.0 for 7 to 14 days at 4uC
prior to dehydration and paraffin embedding. 7 mm sections were
cut and stained with hematoxylin and eosin (H&E).
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4 and 9 month-old mice were sacrificed by CO2 asphyxiation.
Skeleton morphology was imaged at 27 KV for 20 sec using
a Cabinet X-Ray System (Faxitron X-ray Corporation, Wheeling,
Illinois).
Immunohistochemistry
Skeletal tissues were treated with hyaluronidase (0.4% in PBS,
pH 5.0) to unmask epitopes for immunohistochemistry. Immu-
nostaining was performed using the Vectastain ABC kit (Vector
Labs, Burlingame, California), according to the manufacturer’s
instructions. Rabbit anti-mouse VEGF antibody (Santa Cruz
Biotechnology, Santa Cruz, California) was diluted 1:20.
Cell proliferation
Mice were injected intraperitoneally with bromodeoxyuridine
(BrdU) at 100 mg/g body weight and sacrificed 1 hour after
injection. Histological sections of skeletal tissues were prepared
and immunostained for BrdU (Oncogene Research Products, San
Diego, CA). The proliferation rate was calculated as the number of
BrdU-labeled cells divided by the total number of cells in the same
microscopic field.
RNA in situ hybridization of histological sections
The procedures for RNA in situ hybridization of histological
sections were adapted from those described [55].
35[S]-UTP-
labeled antisense or sense RNA probes were prepared. After
hybiridzation, samples were exposed for 7 to 40 days and then
developed using Kodak D-19 developer and fixer, and counter-
stained with Hoechst dye.
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